$SRAX
SRAX, Inc. Stock $srax

$srax Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223038887 Filed on October 31, 2023

Income Statement

Concept	2023 Q4	2022 Q3	2021 Q3
Revenue		$5.309M	$8.313M
YoY Change		-36.14%	218.51%
Cost Of Revenue		$942.0K	$1.804M
YoY Change		-47.78%	105.0%
Gross Profit		$4.367M	$6.509M
YoY Change		-32.91%	276.24%
Gross Profit Margin		82.26%	78.3%
Selling, General & Admin		$3.490M	$7.741M
YoY Change		-54.92%	100.03%
% of Gross Profit		79.92%	118.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$18.00K	$366.0K
YoY Change		-95.08%	7.65%
% of Gross Profit		0.41%	5.62%
Operating Expenses		$3.507M	$8.107M
YoY Change		-56.74%	92.57%
Operating Profit		$860.0K	-$1.598M
YoY Change		-153.82%	-35.56%
Interest Expense		-$5.763M	-$4.270M
YoY Change		34.96%	4.15%
% of Operating Profit		-670.12%
Other Income/Expense, Net		-$4.679M	$1.265M
YoY Change		-469.88%	12550.0%
Pretax Income		-$3.819M	-$4.603M
YoY Change		-17.03%	-29.94%
Income Tax
% Of Pretax Income
Net Earnings		-$3.819M	-$3.829M
YoY Change		-0.26%	-41.72%
Net Earnings / Revenue		-71.93%	-46.06%
Basic Earnings Per Share		-$0.14	-$0.15
Diluted Earnings Per Share		-$0.14	-$153.0K
COMMON SHARES
Basic Shares Outstanding	29.44M shares	26.32M shares	25.02M shares
Diluted Shares Outstanding		26.34M shares	25.02M shares

Balance Sheet

Concept	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.24M	$31.30M
YoY Change	-32.15%	331.71%
Cash & Equivalents	$116.0K	$6.823M
Short-Term Investments	$21.12M	$24.48M
Other Short-Term Assets	$352.0K	$998.0K
YoY Change	-64.73%	202.42%
Inventory
Prepaid Expenses
Receivables	$319.0K	$1.376M
Other Receivables	$499.0K	$0.00
Total Short-Term Assets	$4.425M	$33.67M
YoY Change	-86.86%	280.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$121.0K	$440.0K
YoY Change	-72.5%	-15.38%
Goodwill	$7.706M
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments	$18.20M
YoY Change
Other Assets	$8.000K	$36.00K
YoY Change	-77.78%	80.0%
Total Long-Term Assets	$26.20M	$26.64M
YoY Change	-1.66%	1.3%
TOTAL ASSETS
Total Short-Term Assets	$4.425M	$33.67M
Total Long-Term Assets	$26.20M	$26.64M
Total Assets	$30.63M	$60.32M
YoY Change	-49.22%	71.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.10M	$3.932M
YoY Change	156.84%	62.48%
Accrued Expenses		$124.0K
YoY Change		37.78%
Deferred Revenue
YoY Change
Short-Term Debt	$10.00K	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$1.094M	$1.065M
YoY Change	2.72%	-71.06%
Total Short-Term Liabilities	$31.43M	$26.54M
YoY Change	18.42%	96.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$0.00	$148.0K
YoY Change	-100.0%	-47.14%
Total Long-Term Liabilities	$0.00	$148.0K
YoY Change	-100.0%	-95.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.43M	$26.54M
Total Long-Term Liabilities	$0.00	$148.0K
Total Liabilities	$31.43M	$37.43M
YoY Change	-16.03%	117.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.48M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$807.0K	$22.88M
YoY Change
Total Liabilities & Shareholders Equity	$30.63M	$60.32M
YoY Change	-49.22%	71.64%

Cashflow Statement

Concept	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.819M	-$3.829M
YoY Change	-0.26%	-41.72%
Depreciation, Depletion And Amortization	$18.00K	$366.0K
YoY Change	-95.08%	7.65%
Cash From Operating Activities	-$1.434M	-$6.004M
YoY Change	-76.12%	16.36%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$202.0K
YoY Change	-100.0%	-30.34%
Acquisitions
YoY Change
Other Investing Activities	$698.0K	$2.812M
YoY Change	-75.18%	-507.54%
Cash From Investing Activities	$698.0K	$2.610M
YoY Change	-73.26%	-366.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	592.0K	157.0K
YoY Change	277.07%	-96.05%
NET CHANGE
Cash From Operating Activities	-1.434M	-6.004M
Cash From Investing Activities	698.0K	2.610M
Cash From Financing Activities	592.0K	157.0K
Net Change In Cash	-144.0K	-3.237M
YoY Change	-95.55%	49.17%
FREE CASH FLOW
Cash From Operating Activities	-$1.434M	-$6.004M
Capital Expenditures	$0.00	-$202.0K
Free Cash Flow	-$1.434M	-$5.802M
YoY Change	-75.28%	19.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2022Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001538217
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent		usd
CY2022Q3	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent		usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2021Q3	SRAX	Current Period Change In Fair Value Of Contract Assets CurrentPeriodChangeInFairValueOfContractAssets		usd
	SRAX	Current Period Change In Fair Value Of Contract Assets CurrentPeriodChangeInFairValueOfContractAssets		usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q2	SRAX	Shares Issued For Exercise Of Warrants On Cashless Basis SharesIssuedForExerciseOfWarrantsOnCashlessBasis		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	SRAX	Current Period Change In Fair Value Of Contract Assets CurrentPeriodChangeInFairValueOfContractAssets		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
	SRAX	Loss On Settlement Of Note Receivable LossOnSettlementOfNoteReceivable		usd
	SRAX	Noncontrolling Interest Increase From Warrant Issued NoncontrollingInterestIncreaseFromWarrantIssued		usd
	SRAX	Forgiveness Of Payroll Protection Program Loan ForgivenessOfPayrollProtectionProgramLoan		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	SRAX	Increase Decrease In Contracts Receivable IncreaseDecreaseInContractsReceivable		usd
	SRAX	Increase Decrease Designated Assets For Return Of Captial IncreaseDecreaseDesignatedAssetsForReturnOfCaptial		usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable		usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
	SRAX	Proceeds From Sale Of Designated Assets ProceedsFromSaleOfDesignatedAssets		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	SRAX	Proceeds From Payments For Acquire Other Assets ProceedsFromPaymentsForAcquireOtherAssets		usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
	SRAX	Payments For Preferred Stock Distributions PaymentsForPreferredStockDistributions		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
	SRAX	Payments To Factoring Facilities PaymentsToFactoringFacilities		usd
	SRAX	Repayments Of Factoring Facilities RepaymentsOfFactoringFacilities		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Notes Reduction NotesReduction		usd
	SRAX	Designation Of Marketable Securities For Dividend Distributions DesignationOfMarketableSecuritiesForDividendDistributions		usd
	SRAX	Dividends On Preferred Stock DividendsOnPreferredStock		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021Q3	SRAX	Deemed Dividend On Preferred Stock DeemedDividendOnPreferredStock		usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense		usd
CY2021Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation		usd
CY2022Q3	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent		usd
	SRAX	Marketable Securities Transfers MarketableSecuritiesTransfers		usd
CY2022Q3	us-gaap	Assets Designated To Closed Block Cash And Cash Equivalents AssetsDesignatedToClosedBlockCashAndCashEquivalents		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37916
	dei	Entity Registrant Name EntityRegistrantName	SRAX, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2925231
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1014 S. Westlake Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 14-29
	dei	Entity Address City Or Town EntityAddressCityOrTown	Westlake Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91361
	dei	City Area Code CityAreaCode	323
	dei	Local Phone Number LocalPhoneNumber	205-6109
	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	SRAX
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29438762	shares
CY2022Q3	us-gaap	Cash Cash	116000	usd
CY2021Q4	us-gaap	Cash Cash	1348000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	319000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	821000	usd
CY2022Q3	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	499000	usd
CY2021Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	844000	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2918000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15617000	usd
CY2022Q3	us-gaap	Assets Designated To Closed Block AssetsDesignatedToClosedBlock	221000	usd
CY2021Q4	us-gaap	Assets Designated To Closed Block AssetsDesignatedToClosedBlock	3925000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	352000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	430000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	4425000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	22985000	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	18203000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	935000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	121000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	114000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1443000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	257000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	36000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7706000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	17906000	usd
CY2022Q3	us-gaap	Assets Assets	30625000	usd
CY2021Q4	us-gaap	Assets Assets	43676000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10099000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4095000	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	12862000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	12859000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	844000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	763000	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	10000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	10000	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1094000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1164000	usd
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5478000	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1045000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	3925000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	31432000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22816000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	114000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	31432000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	22930000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52643000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51075000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53476000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30355000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-807000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20746000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30625000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43676000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5309000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6888000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20530000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18963000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	942000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	3354000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9181000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8541000	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2185000	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1892000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5840000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5347000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1305000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	929000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5182000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2562000	usd
CY2022Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	17000	usd
CY2021Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	251000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	403000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	710000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	4449000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	6426000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	20606000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	17160000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	860000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	462000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-76000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1803000	usd
CY2022Q3	SRAX	Financing Costs FinancingCosts	2377000	usd
CY2021Q3	SRAX	Financing Costs FinancingCosts	528000	usd
	SRAX	Financing Costs FinancingCosts	3954000	usd
	SRAX	Financing Costs FinancingCosts	10098000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10200000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1481000	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-47000	usd
CY2022Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-286000	usd
CY2021Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	286000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-6521000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1095000	usd
CY2022Q3	SRAX	Current Period Change In Fair Value Of Marketable Securities CurrentPeriodChangeInFairValueOfMarketableSecurities	-2196000	usd
CY2021Q3	SRAX	Current Period Change In Fair Value Of Marketable Securities CurrentPeriodChangeInFairValueOfMarketableSecurities	-3906000	usd
	SRAX	Current Period Change In Fair Value Of Marketable Securities CurrentPeriodChangeInFairValueOfMarketableSecurities	1696000	usd
	SRAX	Current Period Change In Fair Value Of Marketable Securities CurrentPeriodChangeInFairValueOfMarketableSecurities	-4784000	usd
CY2022Q3	SRAX	Current Period Change In Fair Value Of Contract Assets CurrentPeriodChangeInFairValueOfContractAssets	-22000	usd
	SRAX	Current Period Change In Fair Value Of Contract Assets CurrentPeriodChangeInFairValueOfContractAssets	1491000	usd
CY2022Q3	SRAX	Realized Loss On Designated Assets RealizedLossOnDesignatedAssets	904000	usd
CY2021Q3	SRAX	Realized Loss On Designated Assets RealizedLossOnDesignatedAssets	-2000	usd
	SRAX	Realized Loss On Designated Assets RealizedLossOnDesignatedAssets	1803000	usd
	SRAX	Realized Loss On Designated Assets RealizedLossOnDesignatedAssets	-2000	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	622000	usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-134000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-710000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-134000	usd
CY2022Q3	SRAX	Change In Fair Value Of Preferred Stock ChangeInFairValueOfPreferredStock	281000	usd
CY2021Q3	SRAX	Change In Fair Value Of Preferred Stock ChangeInFairValueOfPreferredStock	134000	usd
	SRAX	Change In Fair Value Of Preferred Stock ChangeInFairValueOfPreferredStock	2513000	usd
	SRAX	Change In Fair Value Of Preferred Stock ChangeInFairValueOfPreferredStock	134000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	33000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1130000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1058000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1145000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4679000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3006000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23044000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12607000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3819000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2544000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23120000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10804000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3819000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2544000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-23120000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10804000	usd
CY2021Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-2059000	usd
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-11755000	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-774000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-1900000	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1285000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-9855000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3819000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3829000	usd
	us-gaap	Profit Loss ProfitLoss	-23120000	usd
	us-gaap	Profit Loss ProfitLoss	-20659000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.14
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.88
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.88
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.48
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.48
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.05
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.05
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.43
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.43
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26341615	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26341615	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25019645	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25019645	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26207696	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26207696	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22707446	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22707446	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20746000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	358000	usd
CY2022Q1	SRAX	Stock Issued During Period Value Stock Options Exercised Net Of Taxes StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxes	-101000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3728000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	24731000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-870000	usd
CY2022Q2	SRAX	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	32000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-23030000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	863000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	281000	usd
CY2022Q3	SRAX	Stock Issued During Period Warrant Modification Expense StockIssuedDuringPeriodWarrantModificationExpense	1788000	usd
CY2022Q3	SRAX	Value Of Shares Issued For Loan Breakup Free ValueOfSharesIssuedForLoanBreakupFree	80000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3819000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-807000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	19225000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	253000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	284000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3447000	usd
CY2021Q1	SRAX	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	12220000	usd
CY2021Q1	SRAX	Warrants Issued As Inducement To Exercise Warrants WarrantsIssuedAsInducementToExerciseWarrants	7737000	usd
CY2021Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	95000	usd
CY2021Q1	SRAX	Noncontrolling Interest Increase From Warrants Issued NoncontrollingInterestIncreaseFromWarrantsIssued	885000	usd
CY2021Q1	SRAX	Noncontrolling Interest Series B Convertible Preferred Stock Issued NoncontrollingInterestSeriesBConvertiblePreferredStockIssued	5775000	usd
CY2021Q1	SRAX	Noncontrolling Interest Increase From Convertible Debt With Conversion Feature NoncontrollingInterestIncreaseFromConvertibleDebtWithConversionFeature	5775000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11944000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	43562000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	253000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	701000	usd
CY2021Q2	SRAX	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	3575000	usd
CY2021Q2	SRAX	Noncontrolling Interest Series B Convertible Preferred Stock Issued NoncontrollingInterestSeriesBConvertiblePreferredStockIssued	86000	usd
CY2021Q2	SRAX	Noncontrolling Interest Increase From Convertible Debt With Conversion Feature NoncontrollingInterestIncreaseFromConvertibleDebtWithConversionFeature	85000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6012000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	42250000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	42250000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	251000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1825000	usd
CY2021Q3	SRAX	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	157000	usd
CY2021Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	6387000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4603000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4603000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	33493000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	33493000	usd
	us-gaap	Profit Loss ProfitLoss	-23120000	usd
	us-gaap	Profit Loss ProfitLoss	-20659000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	9855000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-23120000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10804000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10200000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1481000	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-47000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-6521000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1095000	usd
	SRAX	Current Period Change In Fair Value Of Marketable Securities CurrentPeriodChangeInFairValueOfMarketableSecurities	1696000	usd
	SRAX	Current Period Change In Fair Value Of Marketable Securities CurrentPeriodChangeInFairValueOfMarketableSecurities	-4784000	usd
	SRAX	Current Period Change In Fair Value Of Contract Assets CurrentPeriodChangeInFairValueOfContractAssets	1491000	usd
	SRAX	Realized Loss On Designated Assets RealizedLossOnDesignatedAssets	1803000	usd
	SRAX	Realized Loss On Designated Assets RealizedLossOnDesignatedAssets	-2000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-710000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-134000	usd
	SRAX	Gain Loss On Fair Value In Preferred Stock GainLossOnFairValueInPreferredStock	2513000	usd
	SRAX	Gain Loss On Fair Value In Preferred Stock GainLossOnFairValueInPreferredStock	134000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1788000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	-231000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	757000	usd
	us-gaap	Interest Income Other InterestIncomeOther	33000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	154000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	799000	usd
	SRAX	Loss On Settlement Of Note Receivable LossOnSettlementOfNoteReceivable	35000	usd
	SRAX	Noncontrolling Interest Increase From Warrant Issued NoncontrollingInterestIncreaseFromWarrantIssued	885000	usd
	SRAX	Forgiveness Of Payroll Protection Program Loan ForgivenessOfPayrollProtectionProgramLoan	-1116000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7737000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-60000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-305000	usd
	us-gaap	Depreciation Depreciation	53000	usd
	us-gaap	Depreciation Depreciation	61000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	350000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1061000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	95000	usd
	SRAX	Noncash Financing Expense NoncashFinancingExpense	237000	usd
	SRAX	Noncash Financing Expense NoncashFinancingExpense	213000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-563000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1537000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-105000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	631000	usd
	SRAX	Increase Decrease In Contracts Receivable IncreaseDecreaseInContractsReceivable	1146000	usd
	SRAX	Increase Decrease Designated Assets For Return Of Captial IncreaseDecreaseDesignatedAssetsForReturnOfCaptial	-685000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6002000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	370000	usd
	SRAX	Increase Decrease Deferred Revenues IncreaseDecreaseDeferredRevenues	-13711000	usd
	SRAX	Increase Decrease Deferred Revenues IncreaseDecreaseDeferredRevenues	-16582000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1573000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-396000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-96000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8680000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12775000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5895000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8680000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18670000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3385000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7144000	usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	900000	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3004000	usd
	SRAX	Proceeds From Sale Of Designated Assets ProceedsFromSaleOfDesignatedAssets	506000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	429000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	108000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	388000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	541000	usd
	SRAX	Proceeds From Payments For Acquire Other Assets ProceedsFromPaymentsForAcquireOtherAssets	33000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	4295000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3040000	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	955000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4295000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3995000	usd
	SRAX	Payments For Preferred Stock Distributions PaymentsForPreferredStockDistributions	365000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	284000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	101000	usd
	SRAX	Proceeds From Warrant Exercise ProceedsFromWarrantExercise	32000	usd
	SRAX	Proceeds From Warrant Exercise ProceedsFromWarrantExercise	15953000	usd
	SRAX	Payments To Factoring Facilities PaymentsToFactoringFacilities	5362000	usd
	SRAX	Repayments Of Factoring Facilities RepaymentsOfFactoringFacilities	6184000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	277000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4686000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3153000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16237000	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	4810000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3153000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21047000	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-1232000	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	6502000	usd
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-130000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1348000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	451000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	116000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6823000	usd
	us-gaap	Interest Paid Net InterestPaidNet	77000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14000	usd
	SRAX	Fair Value Of Marketable Securities Received For Revenue Contracts Net FairValueOfMarketableSecuritiesReceivedForRevenueContractsNet	15943000	usd
	SRAX	Fair Value Of Marketable Securities Received For Revenue Contracts Net FairValueOfMarketableSecuritiesReceivedForRevenueContractsNet	26564000	usd
	us-gaap	Notes Reduction NotesReduction	6423000	usd
	SRAX	Designation Of Marketable Securities For Dividend Distributions DesignationOfMarketableSecuritiesForDividendDistributions	6387000	usd
	SRAX	Dividends On Preferred Stock DividendsOnPreferredStock	6387000	usd
CY2022Q3	us-gaap	Cash Cash	116000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zQOrRXpwCQ95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zvqS2cAQEev6">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zuqBA5kjVqR2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_ztq83PphuXS8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with GAAP and require management of the Company to make estimates and assumptions in the preparation of these unaudited Condensed Consolidated Financial Statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most significant areas that require management judgment and which are susceptible to possible change in the near term include, among other items, the Company’s revenue recognition, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisitions, goodwill, other intangible assets, and the valuation of redemption features and other assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	0	usd
CY2021Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	1098000	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	21100000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	15600000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	69000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	130000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zLibXFctoBV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zOdBqMOT5Mpj">Concentration of Credit and Significant Customer Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, accounts receivable and notes receivable. Cash is deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the FDIC insurance limits. The Company has not experienced any loss on these accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022, the Company did not have any customers with accounts receivable balances representing greater than 10% of the Company’s aggregate accounts receivable. As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zthoBa42fX2f" title="Concentration risk percentage">11</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2022 and 2021, the Company had no customers that account for a significant percentage of total revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10200000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1481000	usd
CY2021Q4	SRAX	Issuance Of Acquisitions Shares Description IssuanceOfAcquisitionsSharesDescription	BIGToken (formerly FPVD) completed a merger transaction with BritePool, Inc. (“BritePool”) (the “Merger”) resulting in the Company’s ownership in BIGToken being reduced from 66% to approximately 4.99%.
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	220000	shares
CY2021Q4	SRAX	Loss On Sale Of Equity Investments LossOnSaleOfEquityInvestments	10700000	usd
CY2021Q4	SRAX	Disposal Group Including Discontinued Operation Fair Value Of Series D Stock And Common Stock DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock	31000	usd
CY2021Q4	SRAX	Carrying Amount Of Noncontrolling Interest Of Bigtoken CarryingAmountOfNoncontrollingInterestOfBigtoken	6045000	usd
CY2021Q4	SRAX	Previous Equity Adjustment Of Noncontrolling Interest PreviousEquityAdjustmentOfNoncontrollingInterest	-12510000	usd
CY2021Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-6434000	usd
CY2021Q4	SRAX	Book Basis Of Investment In Bigtoken BookBasisOfInvestmentInBigtoken	4250000	usd
CY2021Q4	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-10684000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	765000	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	2469000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	207000	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	715000	usd
CY2021Q3	SRAX	Disposal Group Including Discontinued Operation Employeerelasted Cost DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost	988000	usd
	SRAX	Disposal Group Including Discontinued Operation Employeerelasted Cost DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost	2649000	usd
CY2021Q3	SRAX	Disposal Group Including Discontinued Operation Selling And Marketing Expense DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense	372000	usd
	SRAX	Disposal Group Including Discontinued Operation Selling And Marketing Expense DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense	861000	usd
CY2021Q3	SRAX	Disposal Group Including Discontinued Operation Platform Cost DisposalGroupIncludingDiscontinuedOperationPlatformCost	78000	usd
	SRAX	Disposal Group Including Discontinued Operation Platform Cost DisposalGroupIncludingDiscontinuedOperationPlatformCost	245000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	101000	usd
	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	412000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	1078000	usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	3483000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	2824000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	8365000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-2059000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-5896000	usd
	SRAX	Deemed Dividend On Preferred Stock DeemedDividendOnPreferredStock	5859000	usd
	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	5859000	usd
CY2021Q3	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-2059000	usd
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-11755000	usd
CY2021Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-2059000	usd
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-11755000	usd
CY2020Q4	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	8000000	usd
CY2020Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	7000000	usd
CY2020Q4	SRAX	Additional Repurchase Of Notes Receivable AdditionalRepurchaseOfNotesReceivable	1000000	usd
CY2020Q4	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000	usd
CY2020Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	107000	usd
CY2020Q4	SRAX	Notes Receivable Amortized Period NotesReceivableAmortizedPeriod	amortized over 3 years
	SRAX	Payment For One Time Offer To Settlement PaymentForOneTimeOfferToSettlement	900000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	935000	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	21121000	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2918000	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	18203000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	15617000	usd
	SRAX	Marketable Securities Addition MarketableSecuritiesAddition	15943000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3385000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-6521000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	533000	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	21121000	usd
	SRAX	Proceed From Sale And Maturity Of Marketable Securities ProceedFromSaleAndMaturityOfMarketableSecurities	3400000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	9900000	usd
	SRAX	Gain On Marketable Securities GainOnMarketableSecurities	6500000	usd
CY2021Q4	us-gaap	Assets Designated To Closed Block Cash And Cash Equivalents AssetsDesignatedToClosedBlockCashAndCashEquivalents	686000	usd
CY2022Q3	us-gaap	Assets Designated To Closed Block Equity Securities At Fair Value AssetsDesignatedToClosedBlockEquitySecuritiesAtFairValue	221000	usd
CY2021Q4	us-gaap	Assets Designated To Closed Block Equity Securities At Fair Value AssetsDesignatedToClosedBlockEquitySecuritiesAtFairValue	3239000	usd
CY2022Q3	us-gaap	Assets Designated To Closed Block AssetsDesignatedToClosedBlock	221000	usd
CY2021Q4	us-gaap	Assets Designated To Closed Block AssetsDesignatedToClosedBlock	3925000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	633000	usd
CY2022Q2	SRAX	Oid Convertible Debentures Face Amount OIDConvertibleDebenturesFaceAmount	1267000	usd
CY2022Q2	SRAX	Oid Convertible Debentures Discount OIDConvertibleDebenturesDiscount	-70000	usd
CY2022Q2	SRAX	Oid Convertible Debentures Short Term OidConvertibleDebenturesShortTerm	1197000	usd
CY2022Q3	SRAX	Oid Convertible Debentures Face Amount OIDConvertibleDebenturesFaceAmount	1146000	usd
CY2022Q3	SRAX	Oid Convertible Debentures Discount OIDConvertibleDebenturesDiscount	-52000	usd
CY2022Q3	SRAX	Oid Convertible Debentures Short Term OidConvertibleDebenturesShortTerm	1094000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1334287	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.02
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	718132	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.27
	SRAX	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P5Y2M12D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	427667	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	110000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.42
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1514752	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	756486	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.30
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	281000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	908000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1139000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	-231000	usd
	SRAX	Cumulative Adjustment To Reverse Stock Based Compensation CumulativeAdjustmentToReverseStockBasedCompensation	1139000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1139000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	253000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	757000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1835000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2022Q3	SRAX	Warrant Expired Shares WarrantExpiredShares	76190	shares
	SRAX	Warrant Expired Shares WarrantExpiredShares	5177327	shares
CY2022Q3	SRAX	Stock Issued During Period Warrant Modification Expense StockIssuedDuringPeriodWarrantModificationExpense	1788000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4774000	usd
	SRAX	Number Of Warrants Cancelled NumberOfWarrantsCancelled	349197	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1710078	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	6309186	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4157692	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.17
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segments
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segments
	SRAX	Number Of Operating Unit NumberOfOperatingUnit	1	integer
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5309000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6888000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20530000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18963000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5309000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6888000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20530000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18963000	usd
CY2022Q3	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	499000	usd
CY2021Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	844000	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	21841000	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1045000	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	20386000	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3925000	usd
CY2022Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	497000	usd

Files In Submission

Name	View Source	Status
0001493152-23-038887-index-headers.html	Edgar Link	pending
0001493152-23-038887-index.html	Edgar Link	pending
0001493152-23-038887.txt	Edgar Link	pending
0001493152-23-038887-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
srax-20220930.xsd	Edgar Link	pending
srax-20220930_cal.xml	Edgar Link	unprocessable
srax-20220930_def.xml	Edgar Link	unprocessable
srax-20220930_lab.xml	Edgar Link	unprocessable
srax-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SRAX
SRAX, Inc. Stock $srax

2023 Q4 Form 10-Q Financial Statement

#000149315223038887 Filed on October 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRAX SRAX, Inc. Stock $srax

2023 Q4 Form 10-Q Financial Statement

#000149315223038887 Filed on October 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRAX
SRAX, Inc. Stock $srax